Manuel Valiente is a highly experienced financial executive with over two decades of work under his belt. He has worked in several international conglomerates such as General Electric and Danaher, gaining expertise in various sectors such as energy, industrial, life sciences, healthcare, oil & gas, and financial services. Valiente is a graduate of ESADE, where he studied for BA and MBA in Corporate & International Finance. Additionally, he completed the Corporate Finance MBA Exchange Program at Stern Business School (NYU). Valiente currently serves as the CFO for Bioprocess at Cytiva. His previous roles include Head of FP&A and finance systems, Biopharma at GE Healthcare; Head of FP&A and R&D finance, Life Sciences at GE Healthcare; Corporate Audit Staff at GE, and several other significant roles. The financial expert has also worked in GE Capital, holding a position in the Finance Management Program. Before this, he started his career as a Financial Analyst at HP.